Mouse Monoclonal SMN/Gemin 1 antibody. Suitable for IHC-P, IP, Flow Cyt, ELISA, WB, ICC/IF and reacts with Human, Xenopus laevis, Mouse samples. Cited in 53 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human SMN1.
View Alternative Names
SMN, SMNT, SMN2, SMNC, SMN1, Survival motor neuron protein, Component of gems 1, Gemin-1
- Flow Cyt
Unknown
Flow Cytometry - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
Overlay histogram showing HepG2 cells stained with ab5831 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab5831, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 100% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
IHC image of ab5831 staining in human normal cervical carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab5831, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
AbReview23998****
Immunocytochemistry/ Immunofluorescence - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
ab5831 staining Gemin 1 in human HeLa cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in methanol and then blocked using 0.2% fish scale gelatin for 1 hour at 25°C. Samples were then incubated with primary antibody at 1/300 for 20 minutes at 25°C. The secondary antibody used was a donkey anti-mouse IgG conjugated to Alexa Fluor® 488 (green) used at a 1/500 dilution. Counterstained with DAPI (blue).
Gemin 1 is clearly visible in the cytoplasm and also as small dots in the nucleus (cajal bodies).
Image courtesy of an anonymous Abreview.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
ICC/IF image of ab5831 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab5831, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- WB
Unknown
Western blot - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
Gemin 1contains a number of potential phosphorylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.
All lanes:
Western blot - Anti-SMN/Gemin 1 antibody [2B1] (ab5831) at 1 µg/mL
Lane 3:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 4:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) (ab65485) at 1/3000 dilution
Predicted band size: 32 kDa
Observed band size: 37 kDa,45 kDa
true
Exposure time: 20min
- WB
AbReview58470****
Western blot - Anti-SMN/Gemin 1 antibody [2B1] (AB5831)
All lanes:
Western blot - Anti-SMN/Gemin 1 antibody [2B1] (ab5831) at 1/100 dilution
All lanes:
Xenopus laevis st II-III oocytes whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG Fc (HRP) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-fc-hrp-ab97265'>ab97265</a>) at 1/25000 dilution
Predicted band size: 32 kDa
Observed band size: 31 kDa
false
Exposure time: 30s
This image is courtesy of an abreview submitted by Samantha Jeschonek.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SMN protein operates within the SMN-Gemin complex a multi-protein assembly important for snRNP biogenesis and pre-mRNA splicing. This complex coordinates the maturation and transport of snRNPs facilitating the processing of precursor mRNAs in the nucleus. SMN and associated Gemin proteins mediate the assembly of Sm proteins onto snRNA ensuring accurate splicing mechanisms necessary for gene expression.
Pathways
The SMN protein is notably involved in the chaperone-assisted assembly pathway related to snRNP biogenesis. It plays a central role in the spliceosome assembly process working closely with Sm proteins and other RNA-binding proteins. Importantly SMN interacts with the ribonucleoprotein complex influencing mRNA splicing which integrates into the broader cell signaling pathways such as the cholinergic agonist pathways and RNA splicing pathways that regulate neuromuscular communication.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (53)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 15:1619171 PubMed40837013
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:597 PubMed40775202
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 26:2500104 PubMed40320567
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of reproduction and development 71:161-167 PubMed40301068
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of cell biology 224: PubMed39602297
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of colorectal disease 39:175 PubMed39477875
2024
Applications
Unspecified application
Species
Unspecified reactive species
Renal failure 46:2415517 PubMed39412062
2024
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology 40:757-772 PubMed39397450
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of general medicine 17:3673-3687 PubMed39206267
2024
Applications
Unspecified application
Species
Unspecified reactive species
Renal failure 46:2387432 PubMed39177245
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com